Drug merger to be based in Ireland
Pharmaceutical companies Alkermes and Elan Drug Technologies are set to merge in a cash and stock transaction valued at $960 million (£585 million).
News
Pharmaceutical companies Alkermes and Elan Drug Technologies are set to merge in a cash and stock transaction valued at $960 million (£585 million).
News
Partner content
Accounting and Finance Software
Accounting and Finance Software